| Samples sequenced, n | ST1 positive | ST2 positive | ST3 positive | ST4 positive | ST6 positive | Single ST n (%) | Two STs n (%) | Of double infections | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ST1 + 2 | ST1 + 3 | ST2 + 3 | |||||||||
By country | |||||||||||
 Azerbaijan | 22 | 3 (14%) | 5 (23%) | 14 (64%) | 0 | 0 | 22 (100%) | 0 |  |  |  |
 Czechia | 8 | 1 (13%) | 3 (38%) | 3 (38%) | 1 (25%) | 0 | 8 (100%) | 0 |  |  |  |
 Jordan | 5 | 1 (20%) | 1 (20%) | 4 (80%) | 0 | 0 | 4 (80%) | 1 (20%) | 1 | 0 | 0 |
 Nigeria | 14 | 8 (57%) | 4 (29%) | 5 (36%) | 0 | 1 (7%) | 10 (71%) | 4 (29%) | 0 | 3 | 1 |
 Sudan | 24 | 14 (58%) | 5 (21%) | 10 (42%) | 0 | 0 | 19 (79%) | 5 (21%) | 3 | 1 | 1 |
 Tanzania | 8 | 2 (25%) | 2 (25%) | 4 (50%) | 0 | 0 | 8 (100%) | 0 |  |  |  |
By diabetes status | |||||||||||
 Type 1 diabetes | 41 | 10 (24%) | 11 (27%) | 22 (54%) | 1 (2.4%) | 0 | 38 (93%) | 3 (7.3%) | 2 | 0 | 1 |
 Healthy controls | 40 | 19 (48%) | 9 (23%) | 18 (45%) | 0 | 1 (2.5%) | 33 (83%) | 7 (18%) | 2 | 4 | 1 |
Total (% of sequenced) | 81 | 29/81 (35.8%) | 20/81 (24.7%) | 40/81 (49.4%) | 1/81 (1.2%) | 1/81 (1.2%) | 71/81 (87.7%) | 10/81 (12.3%) | 4/81 (4.9%) | 4/81 (4.9%) | 2/81 (2.5%) |